Nonetheless, other recent studies have revealed that cell surface markers in APL blasts, such as CD34, CD56, T-cell antigen CD2, the BCR3 isoform, and the FLT3-ITD mutation are associated with hyperleukocytosis and a high risk of relapse22. This evidence concerns the gene NCAM1 and acute promyelocytic leukemia.